tiprankstipranks
Aeterna Zentaris Finalizes Merger Details with Ceapro
Company Announcements

Aeterna Zentaris Finalizes Merger Details with Ceapro

Aeterna Zentaris Inc. (TSE:AEZS) has released an update.

Pick the best stocks and maximize your portfolio:

Aeterna Zentaris Inc. has announced the finalization of details regarding its merger with Ceapro Inc., following a share consolidation where Aeterna shareholders will now receive adjusted shares and warrants. The transaction includes an entitlement to Transaction Warrants for shareholders as of May 29, 2024, with the merger expected to close by June 3, 2024. The deal aims to enhance the company’s pharmaceutical and diagnostic product portfolio, addressing unmet medical needs.

For further insights into TSE:AEZS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskCOSCIENS Biopharma Debuts New Name and Ticker
TheFlyAeterna Zentaris announces name change to Cosciens Biopharma
TipRanks Auto-Generated NewsdeskAeterna Zentaris Release: A Technical Glitch?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App